Cardiac Arrhythmia clinical trials at University of California Health

9 in progress, 3 open to eligible people

Showing trials for

  • MARY-JANE Cannabis and Heart Rhythm Trial

    open to eligible people ages 21 years and up

    Despite recreational cannabis now being legal in 23 states, where more than 100 million Americans reside, studies on the actual health effects are limited. This study is a randomized trial, where each participant will be instructed to consume or…

    at UCSF

  • Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future

    open to eligible people ages 18-100

    Durable left ventricular assist devices (dLVAD) have been increasingly utilized since the mid to late 1990s, with an uptick of utility starting in 2010 following expanded indications for therapy to not only include a bridge to transplantation…

    at UCSF

  • Observational Cohort Study of Fetal Atrial Flutter & Supraventricular Tachycardia

    open to eligible females ages 16-50

    The FAST Trial Registry is a prospective observational cohort study of fetuses with a new diagnosis of atrial flutter (AF) or supraventricular tachycardia (SVT) that is severe enough to consider prenatal treatment (see eligibility criteria below).…

    at UCSF

  • Aveir DR i2i Study

    Sorry, in progress, not accepting new patients

    Prospective, non-randomized, multi-center, international study designed to evaluate the safety and effectiveness of the Aveir™ Dual-Chamber (DR) Leadless Pacemaker system.

    at UCSD

  • Assert-IQ Implantable Cardiac Monitor (ICM) Post Market Study

    Sorry, in progress, not accepting new patients

    This is a prospective, non-randomized, multi-center, real-world post-market study to collect and evaluate data regarding the performance of the enhanced atrial fibrillation detection algorithm of the Assert-IQTM Implantable Cardiac Monitor (ICM)…

    at UCSD

  • ATrial Tachycardia PAcing Therapy in Congenital Heart

    Sorry, not currently recruiting here

    Congenital heart disease (CHD) affects approximately 1% of newborns in the US, with 25% of those affected having critical conditions requiring open heart surgery within one year of birth. Surgical and medical advances have allowed many patients to…

    at UCLA

  • Enlighten Study: the EV-ICD Post Approval Registry

    Sorry, in progress, not accepting new patients

    Medtronic is sponsoring Enlighten: The EV-ICD Post Approval Registry, to further confirm safety and effectiveness of EV-ICD in routine clinical practice, following commercial release of EV-ICD devices.

    at UCSD

  • IVTCC 2.0: a Prospective Multicenter Ventricular Tachycardia Catheter Ablation Registry

    Sorry, accepting new patients by invitation only

    This is a prospective multi-center international registry. The objective of this registry is to collect prospective data on patients undergoing catheter ablation for Ventricular Tachycardia (VT) and Premature Ventricular Contractions (PVC). The…

    at UC Davis UCLA UCSF

  • ViewFlex X ICE First-in-Human Study

    Sorry, not currently recruiting here

    This prospective, acute, first-in-human, non-significant risk study is intended to evaluate a modified version of the ViewFlex X ICE Catheter, Sensor Enabled (ViewFlex X SE) and ViewMate Multi Ultrasound Console (VMM) ICE data integration with the…

    at UCSD

Our lead scientists for Cardiac Arrhythmia research studies include .

Last updated: